Mountain West AETC

Regional Scope

The Mountain West AETC serves Alaska, Colorado, Idaho, Montana, Oregon, North and South Dakota, Utah, Washington, and Wyoming through its central office and local partners.

Contact

For HIV training, technical assistance, and/or capacity building assistance anywhere in the Mountain West AETC region, contact [email protected].

David Spach, MD

Principal Investigator

[email protected]

Laurie Sylla, MHSA

Program Director

[email protected]

Phone: (206) 221-4943

Clinton Amand, BSC, MA

Multimedia Specialist

[email protected]

Rolf Christensen, DDS, MHA

Dental Director

Program Evaluator

Senior Computing Specialist

[email protected]

Antoinette Craig

Regional Program Manager

Fiscal Specialist

Telehealth Manager

Phone: (206) 685-9625

Susan Latta, BA

Program Support Specialist

[email protected]

Hillary Liss, MD

Medical Program Director

[email protected]

Samantha Meiring, BA (Hon)

Practice Transformation Program Coordinator

[email protected]

Victor Ramirez, MSPH

Washington State Training Coordinator

[email protected]

Phone: (206) 543-3319

Lara Strick, MD, MSc

Corrections Program Director

[email protected]

Carrie Van Ness

Central and Eastern Washington Coordinator

[email protected]

Brian Wood, MD

MWAETC HIV ECHO Director/Trainer

[email protected]

Alaska

Alaska AETC

Colorado

Idaho

Idaho AETC

Montana

Montana AETC

Oregon

South Dakota

Dakotas AETC

Utah

Utah AETC

Washington

Wyoming

Wyoming AETC

Resources: 82

Title	Publish Date	Review Date Sort ascending
Stigma and Addiction Training Slides	05/26/2020	04/27/2023
Certification Resources for Health Care Professionals	04/26/2023	04/26/2023
HIV Medication Chart Pad	08/01/2022	11/07/2022
Does this Patient Need PEP?	01/11/2021
Suicide and Overdose among People with HIV during the COVID-19 Pandemic: Updates and Opportunities for Mitigation	03/19/2021
Medications for Methamphetamine Use Disorder	05/21/2021
Integrating Behavioral Health into Primary HIV Care — Covering the Bases	08/16/2021
ART Update: New Guidelines & Medications	12/28/2021
Pneumocystis Pneumonia: Part 1	04/22/2022
Health Inequities and HIV Vulnerability	09/02/2022
Addressing the Increased Risk of Lung Cancer in People with HIV	09/27/2023
HIV & The Treatment of Depression	12/19/2023
Alcohol and Tobacco Use Among People with HIV	04/10/2024
Implementing Telemedicine Webinar Series	08/19/2020
Understanding Frailty	02/22/2021
STIs and PrEP for People Who Inject Drugs	02/12/2021
Operationalizing Use of Long-Acting Injectable ART	07/01/2021
Using HIV-ASSIST to Guide ART Decision-Making	11/23/2021
Unhealthy Alcohol Use Among Persons with HIV: A Modifiable Barrier to Optimal Management of HIV and its Comorbidities	03/16/2022
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV	05/11/2022
HIV Drug Resistance Testing Basics	05/10/2023
Buprenorphine for Opioid Use Disorder	10/25/2023
HIV and the Treatment of Depression II: Antidepressant Selection Part 1 and Part 2	03/19/2024
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region	12/01/2020
Primary Care Considerations for Patients Using Methamphetamines	02/26/2021
Isolated Hepatitis B Core Antibody in People with HIV Infection	05/10/2021
“IM” Thinking About Using Long Acting Injectables	08/13/2021
Revisiting the Invisible Latino HIV Crisis: Examining Progress and Identifying Remaining Gaps in the National Response	12/02/2021
Treatment for STIs: A Guide for Medical Providers	04/01/2022
Cardiovascular Risks of Antiretroviral Therapy	08/05/2022
Clinical Reference Tools for Sexually Transmitted Infections (STI) - Oregon	08/11/2023
Vaccine Update: COVID-19 and RSV	11/08/2023
CROI Update: Prevention	03/26/2024
Hepatitis B Immunity in HIV: Case Vignette	01/15/2021
Microaggressions in Healthcare: Patient Experiences	03/23/2021
Updates in TB Preventive Therapy Guidelines	05/24/2021
Cryptococcosis in People with HIV: Updated Guidelines on Prevention & Treatment	08/31/2021
PrEP for Prevention of HIV in the U.S., 2021 Update	12/30/2021
Fentanyl: A Hidden Epidemic	04/29/2022
Recent Trials of Second-Line ART: Lessons Learned & Applications to Clinical Practice	09/07/2022
Updates to Testing and Prophylaxis for Infants with HIV Exposure	09/27/2023
HIV PrEP: Future of PrEP	01/12/2024
HHS Perinatal Guidelines Update	04/10/2024
HIV Non-Occupational Post-Exposure Prophylaxis (nPEP) and Processes of Patient Care	08/27/2020
Telemedicine and Opioid Use Disorder (OUD) Part 2: Clinical Tips	02/22/2021
Prevention and Treatment of Hepatitis C Infection among People who Use Drugs	04/16/2021
Updates to the HHS Adult and Adolescent HIV Treatment Guidelines	07/02/2021
Dapivirine Ring for HIV PrEP	11/23/2021
Challenging Structural Racism in Medicine: Intro to Key Concepts of Critical Race Theory	03/16/2022
Expedited Partner Therapy (EPT) Fact Sheet for Providers	07/08/2022
Management of HCV and HIV Coinfection	06/13/2023
Immune Reconstitution Syndrome, 2023-Part 2	10/27/2023
Practical Approaches to Polypharmacy	03/26/2024
Telemedicine and Opioid Use Disorder: Regulatory Changes and Evidence	12/23/2020
Pain Management in Individuals with Substance Use Disorders	03/03/2021
Hepatitis C Treatment Update	05/21/2021
Fall Risk Evaluation & Management	08/16/2021
Fentanyl and Other High Potency Synthetic Opioids	12/20/2021
Expedited Partner Therapy in 2022: Updated Guidance and Practical Realities	04/06/2022
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit	08/29/2022
Risk of HIV Transmission with Low Levels of Viremia	09/15/2023
HIV Pre-Exposure Prophylaxis (PrEP) Expansion of Pharmacy-Delivered PrEP	12/15/2023
CROI 2024 Report Back: Treatment Updates	04/10/2024
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV	02/09/2021
Diabetes Medications for Type 2 Diabetes with Focus on HIV: Parts 1 & 2	03/23/2021
Clinically Relevant Drug Interactions with Direct Acting Antivirals (DAAs)	06/14/2021
2021 STI Treatment Guidelines Update	09/10/2021
“Microdosing” Buprenorphine Inductions	02/03/2022
PrEP for PWID: Challenges and Opportunities	05/06/2022
PrEP for Transgender Patients Update	05/03/2023
Screening and Treatment of HPV Lesions to Reduce Anal Cancer: ANCHOR Results and Implications	10/25/2023
Sexual History Taking	03/07/2024
Telemedicine for People with HIV	10/21/2020
Cabotegravir plus Rilpivirine (Cabenuva): Extended Release Injectable Suspension	02/22/2021
What will PrEP Implementation Look Like Post-COVID?	04/29/2021
Treating Hepatitis C Among People who Use Drugs	07/13/2021
Microaggressions in Healthcare: How to Respond	11/23/2021
PrEP for HIV Prevention: The 4-1-1 on 2-1-1	03/22/2022
Pneumocystis Pneumonia: Prevention & Treatment	08/03/2022
Hepatitis B Prevention: New Vaccines and the Boundaries of HBV Protection	07/07/2023
Fentanyl Updates	11/03/2023
Introducing NASTAD's Updated PrEP, PEP, and other HIV Prevention Strategies: Billing and Coding Guide	03/26/2024

Day	Title
05/06 to 05/07	Addressing the Challenges of Rural HIV Case Management (Wyoming) Monday, May 6, 2024 (All day) to Tuesday, May 7, 2024 (All day) Event type: Conferences & Events
05/15	May 2024 Addiction Medicine Webinar: Substance Use Disorders and Pregnancy (Online) Wednesday, May 15, 2024 - 3:00pm EDT to Wednesday, May 15, 2024 - 4:00pm EDT Event type: Webinars
05/16	Sexual Orientation & Gender Identity- Learning Collaborative: Spring 2024 (Online) Thursday, May 16, 2024 - 12:30pm EDT to Thursday, May 16, 2024 - 3:30pm EDT Event type: Webinars
05/23	Gender-Affirming Hormone Therapy Community of Practice (Online) Thursday, May 23, 2024 - 3:00pm EDT to Thursday, May 23, 2024 - 4:00pm EDT Event type: Webinars
06/06 to 06/07	2024 Mountain West AETC HIV Clinical Update for Nurses Conference (Washington) Thursday, June 6, 2024 - 8:00am EDT to Friday, June 7, 2024 - 4:30pm EDT Event type: Conferences & Events

Visit us Online

Regional Scope

Contact

Alaska

Colorado

Idaho

Montana

Oregon

South Dakota

Utah

Washington

Wyoming

Resources: 82